It was September 14, 1978, when untenured UCSD assistant professor, Dr. Ivor Royston, and his research assistant, Howard Birndorf, incorporated Hybritech to explore monoclonal antibodies. A month later, they received their first VC funding and hung a makeshift sign outside an office subleased from a local research institute. Howard “Ted” Greene, a former executive with […]